Management of infections caused by antibiotic-resistant streptococcus pneumoniae

James J. Rahal, Richard J. Hodes, Raymond A. Strikas, James C. Hill, Ian R. Friedland, George H. McCracken

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: In their timely review of the management of infections caused by antibiotic-resistant Streptococcus pneumoniae (Aug. 11 issue),1 Friedland and McCracken omit mention of erythromycin and clindamycin as alternative therapy for penicillin-resistant pneumococcal pneumonia once susceptibility data are known. Table 1 of the article indicates that the incidence of resistance to penicillin in the United States is almost the same as the incidence of erythromycin resistance (7 percent and 6 percent, respectively). Recent data from the Centers for Disease Control and Prevention show a similar percentage of pneumococcal strains resistant to each antibiotic, but only 22 percent of.  . .

Original languageEnglish (US)
Pages (from-to)1774-1775
Number of pages2
JournalNew England Journal of Medicine
Volume331
Issue number26
DOIs
StatePublished - Dec 29 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of infections caused by antibiotic-resistant streptococcus pneumoniae'. Together they form a unique fingerprint.

Cite this